DILH
CC icon

Dai-ichi Life Holdings’s Chemours CC Stock Holding History

Dai-ichi Life Holdings’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-16,490
Closed -$115K – 527
2016
Q1 		$115K Hold
16,490
– – ﹤0.01% 519
2015
Q4 		$88K Hold
16,490
– – ﹤0.01% 548
2015
Q3 		$107K Buy
+16,490
New +$173K ﹤0.01% 554

Other funds holding CC

GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
GCM
Gates Capital Management New York $4.16B AUM 21% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return

Dai-ichi Life Holdings's CC Position: Q2 2016 in Review

Dai-ichi Life Holdings sold out of Chemours (CC) in Q2 2016, closing a stake of 16,490 shares — an estimated $115K sold.

Dai-ichi Life Holdings first reported a position in CC in Q3 2015 and held it in 3 quarters. The position peaked at $115K in Q1 2016. 372 funds tracked by Wall St. Rank hold CC as of Q2 2016.

  • Dai-ichi Life Holdings reported no remaining Chemours position as of Q2 2016 after selling out during the quarter.
  • Dai-ichi Life Holdings sold 16,490 Chemours shares in Q2 2016, an estimated $115K.
  • Dai-ichi Life Holdings first reported a position in Chemours in Q3 2015 and held it in 3 quarters.
  • Dai-ichi Life Holdings's Chemours position peaked at $115K in Q1 2016.
  • 372 funds tracked by Wall St. Rank held Chemours as of Q2 2016.

Based on Dai-ichi Life Holdings's 13F filing for Q2 2016, filed 11 Aug 2016.